[Quantitative determination of coronary reserve in diagnosis of coronary circulatory disorders].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D006332:Cardiomegaly / Q000150:complications / Q000503:physiopathology; D009202:Cardiomyopathies / Q000503:physiopathology; D003095:Collagen Diseases / Q000150:complications / Q000503:physiopathology; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D003331:Coronary Vessels / Q000503:physiopathology*; D004176:Dipyridamole; D006331:Heart Diseases / Q000175:diagnosis; D006349:Heart Valve Diseases / Q000503:physiopathology; D006352:Heart Ventricles; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology; D008297:Male; D011868:Radioisotopes; D013793:Thallium
D000319:Adrenergic beta-Antagonists; D011868:Radioisotopes; D004176:Dipyridamole; D013793:Thallium
Die quantitative Bestimmung der Koronarreserve zur Diagnostik koronarer Durchblutungsstörungen.